Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro-osteogenic paracrine response: TERCELOI clinical trial.
Clin Transl Med. 2021 Jan;11(1):e265. doi: 10.1002/ctm2.265.
Clin Transl Med. 2021.
PMID: 33463067
Free PMC article.
Clinical Trial.